23.00
23.00(0%)
As of Jul 21, 2026
Sutro Biopharma, Inc. [STRO]
Source:
Company Overview
Sutro Biopharma, Inc. is a clinical stage oncology company developing site-specific and novel-format antibody drug conjugates, or ADCs, enabled by our proprietary integrated cell-free protein synthesis platform, XpressCF , and our site-specific conjugation platform, XpressCF .
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | (650) 881-6500 |
| Industry | manufacturing |
| CEO | Jane Chung |
| Website | sutrobio.com |
